These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 16309168

  • 1. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H, Tsunenari T, Onuma E, Sato K, Ogata E, Yamada-Okabe H.
    Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
    [Abstract] [Full Text] [Related]

  • 2. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
    Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ.
    Cancer Res; 2002 Oct 01; 62(19):5571-9. PubMed ID: 12359770
    [Abstract] [Full Text] [Related]

  • 3. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
    Onuma E, Sato K, Saito H, Tsunenari T, Ishii K, Esaki K, Yabuta N, Wakahara Y, Yamada-Okabe H, Ogata E.
    Anticancer Res; 2004 Oct 01; 24(5A):2665-73. PubMed ID: 15517871
    [Abstract] [Full Text] [Related]

  • 4. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
    Son J, Lee JH, Kim HN, Ha H, Lee ZH.
    Biochem Biophys Res Commun; 2010 Jul 23; 398(2):309-14. PubMed ID: 20599715
    [Abstract] [Full Text] [Related]

  • 5. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
    Isowa S, Shimo T, Ibaragi S, Kurio N, Okui T, Matsubara K, Hassan NM, Kishimoto K, Sasaki A.
    Anticancer Res; 2010 Jul 23; 30(7):2755-67. PubMed ID: 20683010
    [Abstract] [Full Text] [Related]

  • 6. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein.
    Bäuerle T, Peterschmitt J, Hilbig H, Kiessling F, Armbruster FP, Berger MR.
    Int J Oncol; 2006 Mar 23; 28(3):573-83. PubMed ID: 16465361
    [Abstract] [Full Text] [Related]

  • 7. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 8. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 9. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.
    Kurio N, Shimo T, Fukazawa T, Takaoka M, Okui T, Hassan NM, Honami T, Hatakeyama S, Ikeda M, Naomoto Y, Sasaki A.
    Exp Cell Res; 2011 May 01; 317(8):1134-46. PubMed ID: 21338601
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N, Matsumine A, Kosugi R, Wakabayashi H, Uchida A.
    Oncol Rep; 2008 Dec 01; 20(6):1497-504. PubMed ID: 19020733
    [Abstract] [Full Text] [Related]

  • 11. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
    Fisher JL, Thomas-Mudge RJ, Elliott J, Hards DK, Sims NA, Slavin J, Martin TJ, Gillespie MT.
    Cancer Res; 2006 Apr 01; 66(7):3620-8. PubMed ID: 16585187
    [Abstract] [Full Text] [Related]

  • 12. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ.
    Cancer Res; 2005 Dec 01; 65(23):11001-9. PubMed ID: 16322249
    [Abstract] [Full Text] [Related]

  • 13. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis.
    Iguchi H, Tanaka S, Ozawa Y, Kashiwakuma T, Kimura T, Hiraga T, Ozawa H, Kono A.
    Cancer Res; 1996 Sep 01; 56(17):4040-3. PubMed ID: 8752176
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo.
    Talon I, Lindner V, Sourbier C, Schordan E, Rothhut S, Barthelmebs M, Lang H, Helwig JJ, Massfelder T.
    Carcinogenesis; 2006 Jan 01; 27(1):73-83. PubMed ID: 16081513
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, Yoneda T, Mundy GR.
    J Clin Invest; 1996 Oct 01; 98(7):1544-9. PubMed ID: 8833902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Constitutive production of parathyroid hormone-related protein (PTHrP) by fibroblasts derived from normal and pathological human breast tissue.
    Cros M, Cataisson C, Cho YM, Berthois Y, Bernard-Poenaru O, Denne M, Graulet AM, De Vernejoul MC, Foley J, Bouizar Z.
    Oncol Res; 2002 Oct 01; 13(3):137-46. PubMed ID: 12549623
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T.
    Cancer Res; 2007 May 01; 67(9):4157-63. PubMed ID: 17483326
    [Abstract] [Full Text] [Related]

  • 19. Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer.
    Duivenvoorden WC, Popović SV, Lhoták S, Seidlitz E, Hirte HW, Tozer RG, Singh G.
    Cancer Res; 2002 Mar 15; 62(6):1588-91. PubMed ID: 11912125
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
    Fleming NI, Trivett MK, George J, Slavin JL, Murray WK, Moseley JM, Anderson RL, Thomas DM.
    Cancer Res; 2009 Sep 15; 69(18):7473-9. PubMed ID: 19723659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.